Cas:21236-55-5 2-[[2-[[(2S)-2-amino-3-(1H-indol-2-yl)propanoyl]amino]acetyl]amino]acetic acid manufacturer & supplier

Chemical Name:2-[[2-[[(2S)-2-amino-3-(1H-indol-2-yl)propanoyl]amino]acetyl]amino]acetic acid

CAS.NO:21236-55-5

Synonyms:Trp-gly-gly dihydrate;Tryptophyl-glycyl-glycine

Molecular Formula:C₁₃H₂₁ClN₂O

Molecular Weight:256.77200

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.10000

Exact Mass:256.13400

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Trp-gly-gly dihydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tryptophyl-glycyl-glycine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trp-gly-gly dihydrate Use and application,Tryptophyl-glycyl-glycine technical grade,usp/ep/jp grade.

Related News: The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 2-amino-4-(3,4-dichlorophenyl)thiophene-3-carbonitrile manufacturers Competition is indeed “severe” from local firms, Wang said, but the company is working to add new drugs and indications to the market and is noticing increased volumes from national reimbursement deals. 4-Bromo-6-methylpyridin-2-ol suppliers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. α-D-Glucopyranosyl-(1->6)-α-D-glucopyranosyl-(1->4)-α-D-glucopyranosyl-(1->4)-D-glucose vendor & factory.